Dr. Matteo Trucco, MD
Claim this profileCleveland Clinic
Area of expertise
Soft Tissue Sarcoma
Matteo Trucco, MD has run 5 trials for Soft Tissue Sarcoma. Some of their research focus areas include:
Osteosarcoma
Matteo Trucco, MD has run 2 trials for Osteosarcoma. Some of their research focus areas include:
Affiliated Hospitals
Cleveland Clinic
Cleveland Clinic, Case Comprehensive Cancer Center
Clinical Trials Matteo Trucco, MD is currently running
Repotrectinib
for Solid Tumors in Young Patients
Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring anaplastic lymphoma kinase (ALK), receptor tyrosine kinase encoded by the gene ROS1 (ROS1), or neurotrophic receptor kinase genes encoding TRK kinase family (NTRK1-3) alterations to estimate the Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD) and select the Pediatric Recommended Phase 2 Dose (RP2D). Phase 2 will determine the anti-tumor activity of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring ROS1 or NTRK1-3 alterations.
Recruiting
1 award
Phase 1 & 2
14 criteria
Disulfiram + Copper Gluconate + Liposomal Doxorubicin
for Sarcoma
This trial tests a new treatment combining a drug for alcoholism, a copper supplement, and a special chemotherapy for patients whose sarcomas came back or didn't respond to initial treatment. The goal is to make the chemotherapy work better by stopping the cancer from resisting it. Researchers are checking if this combination is safe and effective.
Recruiting
3 awards
Phase 1
More about Matteo Trucco, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Matteo Trucco, MD has experience with
- Copper Gluconate
- Disulfiram
- Liposomal Doxorubicin
- Repotrectinib
- Actinomycin D
- Cyclophosphamide
Breakdown of trials Matteo Trucco, MD has run
Soft Tissue Sarcoma
Osteosarcoma
Rhabdomyosarcoma
Ewing Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matteo Trucco, MD specialize in?
Matteo Trucco, MD focuses on Soft Tissue Sarcoma and Osteosarcoma. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are NTRK positive.
Is Matteo Trucco, MD currently recruiting for clinical trials?
Yes, Matteo Trucco, MD is currently recruiting for 2 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Matteo Trucco, MD has studied deeply?
Yes, Matteo Trucco, MD has studied treatments such as Copper Gluconate, Disulfiram, Liposomal Doxorubicin.
What is the best way to schedule an appointment with Matteo Trucco, MD?
Apply for one of the trials that Matteo Trucco, MD is conducting.
What is the office address of Matteo Trucco, MD?
The office of Matteo Trucco, MD is located at: Cleveland Clinic, Cleveland, Ohio 44195 United States. This is the address for their practice at the Cleveland Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.